BiotechTube
Home/Newron Pharmaceuticals/Roberto Galli
RG

Roberto Galli

Chief Financial Officer

Newron Pharmaceuticals

Therapeutic Areas

NeurologyPsychiatry

Newron Pharmaceuticals Pipeline

DrugIndicationPhase
Xadago (safinamide)Parkinson's diseaseApproved
Evenamide (NW-3509)Schizophrenia (treatment-resistant)Phase III
SarizotanRett SyndromePhase III
Newron 2024Undisclosed rare CNS diseasePreclinical

Leadership Team at Newron Pharmaceuticals

SW
Stefan Weber
Chief Executive Officer
RA
Ravi Anand
Chief Medical Officer
LR
Lucio Rovati
Director of R&D and Chairman of the Board
View full Newron Pharmaceuticals profile